In silico quantitative structure pharmacokinetic relationship modeling for quinolone drugs: Biological half-life

Asian Journal of Chemistry

Volumn 22, Issue 6, 2010, Pages 4880-4890

  Paul, Yash ^b   Dhake, Avinash S ^c   Parle, Milind ^d   Bhupinder, Singh ^a  

^a PANJAB UNIVERSITY   (India)

^b Lord Shiva Charitable Trust Sirsa   (India)

^c SMBT College of Pharmacy   (India)

^d GURU JAMBHESHWAR UNIVERSITY OF SCIENCE AND TECHNOLOGY   (India)

Author keywords

Biological hal life; Distribution; In silico absorption; Metabolism and excretion; QSPkR; Quinolones

Indexed keywords

EID: 77955704021     PISSN: 09707077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. A.P. Kamath, R.D. Puri and V.M. Kulkarni, Indian Drugs, 29, 626 (1986).
2. H. van de Waterbeemed and E. Gifford, Drug Discov., 2, 192 (2003).
3. S. Ekins, C. Wallter, P. Swaan, G. Cruciani, S. Wrighton and J. Wikel, J. Pharmacol. Toxicol. Methods, 44, 251 (2000).
4. A.P. Beresford, M. Segall and M.H. Tabit, Curr. Opin. Drug Discov. Dev., 7, 36 (2004).
5. V. Karlis, A. Tsantili-Kakoulidou and P. Macheras, Eur. J. Pharm. Sci., 20, 115 (2003).
6. B. Singh, A.S. Dhake, D. Sethi and Y. Paul, Pharm. Rev., 29, 93 (2007).
7. Y. Paul, A.S. Dhake and B. Singh, Asian J. Chem., 21, 4728 (2009).
8. M. Grover, B. Singh, M. Bakshi and S. Singh, Pharm. Sci. Tech. Today, 3, 28 (2000).
9. Y. Paul, A.S. Dhake, M. Parle and B. Singh, Res. J. Pharm. Tech., 1, 106 (2008).
10. L. Shargel, S. Wu-Pong and Y.U. Andrew, Applied Biopharmaceutics and Pharmacokinetics, McGraw Hill Companies Inc, New York, edn. 5, pp. 259, 864-866 (2005).
11. D.C. Hooper and J.S. Wolfson, Quinolone Antimicrobial Agents, American Society for Microbio;logy, Washington, edn. 2, pp. 195-223 (1993).
12. J. Maryadele and O. Neil, The Merck Index: An Encyclopedia of Chemicals, Drugs and Biologicals, Merck Research Laboratories Division of Merck and Co. Inc., USA, edn. 14 (2006).
13. L.L. Bruton, J.S. Laza and K.L. Parker, Goodman Gilman's: The Pharmacological Basis of Therapeutics, McGraw-Hill Medical Publishing Division, New York, edn. 11, pp. 940-950 (2006).
14. D. Cheng, W.-R. Xu and C.-X. Liu, World J. Gastroenterol., 13, 2496 (2007).
15. J.G. Topliss and R.J. Costello, J. Med. Chem., 15, 1066 (1972).
16. H. van de Waterbeemd, Chemometric Methods used in Drug Discovery, in Structure Property Correlations in Drug Research, RG Landes Company: Texas, pp. 55-80 (1996).
17. Y. Paul, M. Parle, A.S. Dhake and B. Singh, Asian J. Chem., 21, 5483 (2009).
18. K. Reed, K. Mereish and B. Jensen, J. Pharm. Sci., 73, 237 (1984).
19. R.S. Markin and W.J. Murray, Pharm. Res., 5, 408 (1988).
20. E.J. Lein and X.C. Ou, Acta Pharm. Jugosl., 34, 123 (1984).
21. F. Gaspari and M. Bonati, J. Pharm. Pharmacol., 39, 252 (1987).
22. S. Kaul and W.A. Ritschel, Eur. J. Drug Metab. Pharmacokinet., 15, 211 (1990).